2023 was a troublesome 12 months to the biopharma marketplace, with quite a few corporations downsizing and restructuring their workforces to remain afloat. There are signs of recovery, as mergers and acquisitions picked up over the pharmaceutical and existence sciences marketplace inside the latter Component of 2023 and possess ongoing https://sites.google.com/view/bio-sites/blog